Health TrialsbyHealthPanel

Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients

ConditionChronic Kidney Disease Requiring Chronic Dialysis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Tartu

About this trial

This study looks at how measurements of body composition from Bioelectrical Impedance Analysis (BIA) and estimates of kidney function (eGFR) can be applied together to better assess the health of people on hemodialysis. Many dialysis patients struggle with malnutrition, muscle loss, and fluid imbalances, but current assessment methods rely on unsophisticated tests and observations. By combining BIA and eGFR, this study aims to provide a more accurate and non-invasive way to monitor nutrition and overall health, which could lead to better treatment decisions and improved patient outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Patients on chronic hemodialysis for at least 6 months

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

30 Participants
are grouped into 1 trial group
Group A: Patients undergoing hemodialysis at Tartu University Hospital

Trial outcomes

Primary outcomes

1

Correlation between body composition and estimated glomerular filtration rate

The primary outcome measure of this study is the correlation between body composition as fat free mass (kg) derived from Bioelectrical Impedance Analysis (BIA) and estimated glomerular filtration rate (eGFR) (ml/minute) in hemodialysis patients.

Time frame
3 months

Secondary outcomes

1

Assessment of malnutrition in patients on chronic hemodialysis

The study assesses the prevalence of malnutrition and protein-energy wasting (PEW) in the study population using fat-free mass (kg) from BIA and eGFR (ml/minute) data.

Time frame
3 months
2

Assessment of body composition in patients on chronic hemodialysis

Total body water (ml) derived from BIA will also be compared to the eGFR assessments

Time frame
3 months
3

Assessment of phase angle in patients on chronic hemodialysis

Phase angle (from BIA) will be compared to the eGFR assessments

Time frame
3 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Tartu

Lead sponsor

Source ClinicalTrials.gov
Apply now